Cumberland Pharmaceuticals Investor Relations Material

Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development, acquisition, and commercialization of prescription medicines. The company's portfolio includes products for hospital acute care, gastroenterology, and rheumatology, addressing the needs of patients in critical care settings. Cumberland Pharmaceuticals is involved in all aspects of the product lifecycle, from clinical research to regulatory approval and distribution. Its target markets include healthcare providers, hospitals, and outpatient facilities across the United States. The company is headquartered in Nashville, Tennessee, and its shares are listed on the NASDAQ.